Patents by Inventor Sunil Gupta

Sunil Gupta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180278459
    Abstract: The disclosed technology relates to assigning network agents to communication modules. A network policy system is configured to assign network agents to buckets based on an agent identifier of each agent. The network policy system can assign buckets to communication modules. When a failed communication module is detected, the network policy system can reassigning buckets assigned to the failed communication module to operational communication modules.
    Type: Application
    Filed: March 27, 2017
    Publication date: September 27, 2018
    Inventors: Rohit Prasad, Hai Vu, Shih-Chun Chang, Hoang Nguyen, Shashi Gandham, Navindra Yadav, Praneeth Vallem, Sunil Gupta, Ravi Prasad, Paul Lesiak
  • Publication number: 20180278480
    Abstract: The disclosed technology relates to intent driven network management. A system is configured to maintain an inventory store comprising records for a set of network entities in a network, wherein each network entity in the set of network entities is associated with a record in the inventory store. The system receives a user intent statement comprising an action and a flow filter representing network data flows on which the action is to be applied and queries, based on the flow filter, the inventory store to identify a plurality of network entities in the set of network entities to which the user intent statement applies. The system generates a plurality of network policies that implement the user intent statement based on the plurality of network entities and the action and enforces the plurality network policies.
    Type: Application
    Filed: March 27, 2017
    Publication date: September 27, 2018
    Inventors: Rohit Prasad, Shashi Gandham, Hoang Nguyen, Abhishek Singh, Shih-Chun Chang, Navindra Yadav, Ali Parandehgheibi, Paul Mach, Rachita Agasthy, Ravi Prasad, Varun Malhotra, Michael Watts, Sunil Gupta
  • Publication number: 20180125810
    Abstract: The invention relates to a compound of formula: which may be in base form or in the form of a hydrate or a solvate, in combination with prednisone or prednisolone, for its use as a medicament in the treatment of prostate cancer, particularly metastatic prostate cancer, especially for patients who are not catered for by a taxane-based treatment.
    Type: Application
    Filed: June 20, 2017
    Publication date: May 10, 2018
    Inventor: Sunil GUPTA
  • Patent number: 9822115
    Abstract: Compounds of Formula (I), their preparation, and use in preventing or treating a bacterial infection are disclosed.
    Type: Grant
    Filed: January 21, 2015
    Date of Patent: November 21, 2017
    Assignee: WOCKHARDT LIMITED
    Inventors: Prasad Keshav Deshpande, Satish Bhawsar, Sanjay Raikar, Sanjay Kisan Dabhade, Laxmikant Pavase, Amit Mishra, Sunil Gupta, Vikas Vitthalrao Deshmukh, Sunil Bhaginath Jadhav, Rajesh Kale, Sachin Bhagwat, Ravindra Dattatraya Yeole, Mahesh Vithalbhai Patel
  • Publication number: 20170319550
    Abstract: This invention relates to the treatment of uveitis, in particular posterior infectious uveitis. In specific embodiments, the invention provides for methods of treating uveitis and/or infectious uveitis comprising administration of a sustained-release system containing 5-amino-[4-(4-chlorobenzoyl)-3,5-dichlorobenzyl]-1,2,3-triazole-4-carboxamide) and optionally a glucocorticoid. In one embodiment, the glucocorticoid is dexamethasone. In another embodiment, the sustained-release system comprises a polmyer such as e.g. polylactic-coglycolic acid.
    Type: Application
    Filed: March 20, 2017
    Publication date: November 9, 2017
    Applicant: GEN PHARMA HOLDINGS, LLC
    Inventor: Sunil GUPTA
  • Patent number: 9629826
    Abstract: This invention relates to the treatment of uveitis, in particular posterior infectious uveitis. In specific embodiments, the invention provides for methods of treating uveitis and/or infectious uveitis comprising administration of a sustained-release system containing 5-amino-[4-(4-chlorobenzoyl)-3,5-dichlorobenzyl]-1,2,3-triazole-4-carboxamide) and optionally a glucocorticoid. In one embodiment, the glucocorticoid is dexamethasone. In another embodiment, the sustained-release system comprises a polymer such as e.g. polylactic-coglycolic acid.
    Type: Grant
    Filed: December 11, 2015
    Date of Patent: April 25, 2017
    Assignee: GEN PHARMA HOLDINGS, LLC
    Inventor: Sunil Gupta
  • Publication number: 20160355516
    Abstract: Compounds of Formula (I), their preparation, and use in preventing or treating a bacterial infection are disclosed.
    Type: Application
    Filed: January 21, 2015
    Publication date: December 8, 2016
    Inventors: Prasad Keshav DESHPANDE, Satish BHAWSAR, Sanjay RAIKAR, Sanjay Kisan DABHADE, Laxmikant PAVASE, Amit MISHRA, Sunil GUPTA, Vikas DESHMUKH, Sunil Bhaginath JADHAV, Rajesh KALE, Sachin BHAGWAT, Ravindra Dattatraya YEOLE, Mahesh Vithalbhai PATEL
  • Publication number: 20160331717
    Abstract: The present invention relates to the compound having the following formula (I): which may be in base form or in the form of a hydrate or a solvate, for its use as a medicament in the treatment of cancer in patients with hepatic impairment.
    Type: Application
    Filed: May 12, 2016
    Publication date: November 17, 2016
    Inventors: Mustapha CHADJAA, Jean-François DEDIEU, Sunil GUPTA, Dalila SELLAMI, Dorothée SEMIOND
  • Patent number: 9381200
    Abstract: Compounds of Formula (I), their preparation and use in preventing or treating bacterial infection is disclosed.
    Type: Grant
    Filed: July 9, 2015
    Date of Patent: July 5, 2016
    Assignee: WOCKHARDT LIMITED
    Inventors: Mahesh Vithalbhai Patel, Prasad Keshav Deshpande, Satish Bhawasar, Sachin Bhagwat, Mohammad Alam Jafri, Amit Mishra, Laxmikant Pavase, Sunil Gupta, Rajesh Kale, Sanjeev Joshi
  • Publication number: 20160106718
    Abstract: This invention relates to the treatment of uveitis, in particular posterior infectious uveitis. In specific embodiments, the invention provides for methods of treating uveitis and/or infectious uveitis comprising administration of a sustained-release system containing 5-amino-[4-(4-chlorobenzoyl)-3,5-dichlorobenzyl]-1,2,3-triazole-4-carboxamide) and optionally a glucocorticoid. In one embodiment, the glucocorticoid is dexamethasone. In another embodiment, the sustained-release system comprises a polymer such as e.g. polylactic-coglycolic acid.
    Type: Application
    Filed: December 11, 2015
    Publication date: April 21, 2016
    Applicant: Gen Pharma Holdings LLC
    Inventor: Sunil GUPTA
  • Publication number: 20160106717
    Abstract: This invention relates to the treatment of uveitis, in particular posterior infectious uveitis. In specific embodiments, the invention provides for methods of treating uveitis and/or infectious uveitis comprising administration of a sustained-release system containing 5-amino-[4-(4-chlorobenzoyl)-3,5-dichlorobenzyl]-1,2,3-triazole-4-carboxamide) and optionally a glucocorticoid. In one embodiment, the glucocorticoid is dexamethasone. In another embodiment, the sustained-release system comprises a polymer such as e.g. polylactic-coglycolic acid.
    Type: Application
    Filed: October 15, 2015
    Publication date: April 21, 2016
    Applicant: Gen Pharma Holdings LLC
    Inventor: Sunil Gupta
  • Publication number: 20160083412
    Abstract: The invention relates to ketolide compounds of Formula (1) and their pharmaceutically acceptable salts, solvates, hydrates, polymorphs and stereoisomers having antimicrobial activity. The invention also provides pharmaceutical compositions containing the compounds of invention and methods of treating or preventing microbial infections with the compounds of invention, wherein, T is —C*H(R1)—P-Q; R, is hydrogen; unsubstituted or substituted lower alkyl, cycloalkyl or aryl; P is heteroaryl ring; Q is unsubstituted or substituted aryl or heteroaryl ring; and P is attached to Q via carbon-carbon link; and R3 is hydrogen or fluorine, With the provision that when R, is hydrogen, R3 is fluorine.
    Type: Application
    Filed: September 19, 2015
    Publication date: March 24, 2016
    Inventors: Bharat TRIVEDI, Prasad Deshpande, Ravikumar Tadiparthi, Sunil Gupta, Santosh Diwakar, Shivaji Pawar, Vijay Patil, Deepak Dekhane, Mahesh Patel, Satish Bhavsar, Amit Mishra, Manish Solanki, Mohammad Jafri, Sachin Bhagwat
  • Publication number: 20150328201
    Abstract: Compounds of Formula (I), their preparation and use in preventing or treating bacterial infection is disclosed.
    Type: Application
    Filed: July 9, 2015
    Publication date: November 19, 2015
    Inventors: Mahesh Vithalbhai PATEL, Prasad Keshav DESHPANDE, Satish BHAWASAR, Sachin BHAGWAT, Mohammad Alam JAFRI, Amit MISHRA, Laxmikant PAVASE, Sunil GUPTA, Rajesh KALE, Sanjeev JOSHI
  • Patent number: 9175031
    Abstract: The invention relates to ketolide compounds of Formula (I) and their pharmaceutically acceptable salts, solvates, hydrates, polymorphs and stereoisomers having antimicrobial activity. The invention also provides pharmaceutical compositions containing the compounds of invention and methods of treating or preventing microbial infections with the compounds of invention, wherein, T is —C*H(R1)—P-Q; R1 is hydrogen; unsubstituted or substituted lower alkyl, cycloalkyl or aryl; P is heteroaryl ring; Q is unsubstituted or substituted aryl or heteroaryl ring; and P is attached to Q via carbon-carbon link; and R3 is hydrogen or fluorine, With the provision that when R1 is hydrogen, R3 is fluorine.
    Type: Grant
    Filed: February 3, 2011
    Date of Patent: November 3, 2015
    Assignee: WOCKHARDT LIMITED
    Inventors: Bharat Trivedi, Prasad Deshpande, Ravikumar Tadiparthi, Sunil Gupta, Santosh Diwakar, Shivaji Pawar, Vijay Patil, Deepak Dekhane, Mahesh Patel, Satish Bhavsar, Amit Mishra, Manish Solanki, Mohammad Jafri, Sachin Bhagwat
  • Patent number: 9132133
    Abstract: Compounds of Formula (I), their preparation and use in preventing or treating bacterial infection is disclosed.
    Type: Grant
    Filed: January 30, 2015
    Date of Patent: September 15, 2015
    Assignee: Wockhardt Ltd.
    Inventors: Mahesh Vithalbhai Patel, Prasad Keshav Deshpande, Satish Bhawasar, Sachin Bhagwat, Mohammad Alam Jafri, Amit Mishra, Laxmikant Pavase, Sunil Gupta, Rajesh Kale, Sanjeev Joshi
  • Publication number: 20150174133
    Abstract: Compounds of Formula (I), their preparation and use in preventing or treating bacterial infection is disclosed.
    Type: Application
    Filed: January 30, 2015
    Publication date: June 25, 2015
    Applicant: WOCKHARDT LIMITED
    Inventors: Mahesh Vithalbhai PATEL, Prasad Keshav Deshpande, Satish Bhawasar, Sachin Bhagwat, Mohammad Alam Jafri, Amit Mishra, Laxmikant Pavase, Sunil Gupta, Rajesh Kale, Sanjeev Joshi
  • Publication number: 20150118182
    Abstract: The invention relates to a compound of formula: which may be in base form or in the form of a hydrate or a solvate, in combination with prednisone or prednisolone, for its use as a medicament in the treatment of prostate cancer, particularly metastatic prostate cancer, especially for patients who are not catered for by a taxane-based treatment.
    Type: Application
    Filed: December 18, 2014
    Publication date: April 30, 2015
    Inventor: Sunil GUPTA
  • Publication number: 20150104411
    Abstract: The invention relates to a compound of formula: which may be in base form or in the form of a hydrate or a solvate, in combination with prednisone or prednisolone, for its use as a medicament in the treatment of prostate cancer, particularly metastatic prostate cancer, especially for patients who are not catered for by a taxane-based treatment.
    Type: Application
    Filed: December 18, 2014
    Publication date: April 16, 2015
    Inventor: Sunil GUPTA
  • Patent number: 8987297
    Abstract: Compounds of Formula (I), their preparation and use in preventing or treating bacterial infection is disclosed.
    Type: Grant
    Filed: August 6, 2014
    Date of Patent: March 24, 2015
    Assignee: Wockhardt Ltd.
    Inventors: Mahesh Vithalbhai Patel, Prasad Keshav Deshpande, Satish Bhawasar, Sachin Bhagwat, Mohammad Alam Jafri, Amit Mishra, Laxmikant Pavase, Sunil Gupta, Rajesh Kale, Sanjeev Joshi
  • Patent number: 8927592
    Abstract: The invention relates to a compound of formula: which may be in base form or in the form of a hydrate or a solvate, in combination with prednisone or prednisolone, for its use as a medicament in the treatment of prostate cancer, particularly metastatic prostate cancer, especially for patients who are not catered for by a taxane-based treatment.
    Type: Grant
    Filed: April 26, 2012
    Date of Patent: January 6, 2015
    Assignee: Aventis Pharma SA
    Inventor: Sunil Gupta